pfizer inc: PFE, +0.47% and Merck & Co, according to Market Watch. MRK, +1.98% —to be more transparent about when and why they raise prices. The investors, members of the New York-based Interfaith Center on Corporate Responsibility, are asking 17 drug companies—including Johnson & Johnson JNJ, +0.31% Pfizer Inc. The investors, which own shares in the drug companies being targeted, say rising costs are putting prescription drugs out of reach for many patients. The health of the economy depends on the health of the people, said Donna Meyer, director of shareholder advocacy for ICCR member Mercy Investment Services Inc. of St. That could lead to long-term challenges for the companies, they say.
(news.financializer.com). As
reported in the news.
Tagged under pfizer inc, shareholder advocacy topics.